Show simple item record

dc.contributor.advisorHutt, Peter Bartonen_US
dc.contributor.authorHartgraves, Tiffanyen_US
dc.date.accessioned2012-06-07T20:11:39Z
dc.date.issued2002en_US
dc.identifier.citationDTC Prescription Drug Advertising: The History and Impact of FDA Regulation (2002 Third Year Paper)en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8852117
dc.description.abstractThis paper traces the history of direct-to-consumer (DTC) advertising for prescription drugs in the United States, beginning with the enactment of the Federal Food, Drug, and Cosmetics Act in 1938 and continuing through the current state of FDA regulation. A detailed analysis of how the promulgation of DTC ads has affected a variety of groups (including consumers, the medical profession, pharmaceutical companies, the government, and advertisers) is followed by a brief look at a well-known DTC ad campaign (Schering-Plough’s Claritin). The paper questions whether DTC ads are a constructive or a deconstructive element of the American healthcare system and concludes by offering an opinion on the current state of DTC advertising regulation and enforcement by the FDA.en
dc.language.isoen_USen
dash.licenseLAAen_US
dc.subjectFood and Drug Lawen
dc.subjectDTCen
dc.subjectadvertisingen
dc.subjectpolicyen
dc.subjectdrugsen
dc.titleDTC Prescription Drug Advertising: The History and Impact of FDA Regulationen
dc.typePaper (for course/seminar/workshop)en_US
dc.date.available2012-06-07T20:11:39Z
dash.authorsorderedfalse


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record